ALLO Allogene Therapeutics, Inc.

Fundamentals / CIK 0001737287 / USD

Allogene Therapeutics, Inc. reported $0 in revenue and a net loss of $174.5M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ALLO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$148.4M$74.20M$0-$328.0MFY 2018 Net Income: -$211.5M2018FY 2019 Revenue: $0FY 2019 Net Income: -$184.6M2019FY 2020 Revenue: $0FY 2020 Net Income: -$250.2M2020FY 2021 Revenue: $114.1MFY 2021 Net Income: -$182.1M2021FY 2022 Revenue: $156KFY 2022 Net Income: -$340.4M2022FY 2023 Revenue: $95KFY 2023 Net Income: -$327.3M2023FY 2024 Revenue: $22KFY 2024 Net Income: -$257.6M2024FY 2025 Revenue: $0FY 2025 Net Income: -$190.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $22K $95K $156K $114.1M $0 $0 --
Research & Development $150.2M $192.3M $242.9M $256.4M $220.2M $193.0M $144.5M $151.9M
Total Operating Expenses $209.3M $273.2M $327.8M $335.7M $294.3M $258.2M $202.0M $192.8M
Operating Income -$209.3M -$273.2M -$327.7M -$335.5M -$180.2M -$258.2M -$202.0M -$192.8M
EBITDA -$197.0M -$259.6M -$313.5M -$321.2M -$169.7M -$250.8M -$197.4M -$191.8M
Interest Expense $1.07M $181K $0 -- -- $0 $0 $3.36M
Income Before Tax -$190.9M -$257.1M -$327.3M -- -$257.0M -$250.2M -$184.9M -$211.6M
Income Tax Expense $0 $443K $0 $0 $0 $0 -$331K -$117K
Net Income -$190.9M -$257.6M -$327.3M -$340.4M -$182.1M -$250.2M -$184.6M -$211.5M
Basic EPS -$0.87 -$1.32 -$2.09 -$2.38 -$1.34 -$2.08 -$1.83 -$7.31
Diluted EPS -$0.87 -$1.32 -$2.09 -$2.38 -$1.34 -$2.08 -$1.83 -$7.31
Basic Shares Outstanding 220.6M 194.8M 156.9M 143.1M 135.8M 120.4M 101.1M 28.9M
Diluted Shares Outstanding 220.6M 194.8M 156.9M 143.1M 135.8M 120.4M 101.1M 28.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $4.64M -- $0 $0 $0 $0 $0
Research & Development $41.93M $30.72M $32.00M $28.63M $31.16M $40.16M $50.20M $44.97M
Total Operating Expenses $54.79M $51.56M $46.09M $42.40M $44.90M $56.82M $65.19M $60.49M
Operating Income -$54.79M -$46.92M -$46.09M -$42.40M -$44.90M -$56.82M -$65.19M -$60.49M
EBITDA -$52.21M -$44.27M -$43.22M -$39.35M -$41.80M -$53.71M -$62.09M -$57.26M
Interest Expense $379K $343K $300K $313K $344K $268K $150K $81K
Net Income -$50.37M -$42.68M -$42.61M -$38.81M -$41.40M -$50.94M -$59.73M -$59.94M
Basic EPS -$0.15 -$0.13 -$0.18 -- -$0.19 -$0.23 -$0.28 --
Diluted EPS -$0.15 -$0.13 -$0.18 -- -$0.19 -$0.23 -$0.28 --
Basic Shares Outstanding 346.1M 328.9M 240.3M -- 222.0M 218.9M 215.4M --
Diluted Shares Outstanding 346.1M 328.9M 240.3M -- 222.0M 218.9M 215.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Sep 30 Jun 30 Mar 31 Dec 31 Sep 30 Jun 30 Mar 31
Cash & Cash Equivalents $51.69M $75.22M $83.16M $69.25M $154.8M $109.9M $61.90M $74.36M $96.04M $84.51M
Short-Term Investments $198.5M $217.3M $365.5M $396.3M $337.2M $361.3M $455.4M $477.9M $394.5M $364.5M
Cash & Short-Term Investments $258.3M $373.1M $448.7M $497.7M $544.5M $514.0M $576.5M $637.3M $686.1M $733.1M
Total Current Assets $257.7M $303.4M $459.1M $473.5M $502.1M $481.5M $528.8M $569.1M $513.0M $469.7M
Property, Plant & Equipment, Net $72.84M $86.06M $99.48M $102.8M $106.4M $109.8M $112.8M $114.4M $117.2M $120.2M
Long-Term Investments $8.04M $80.67M $0 $32.17M $52.59M $42.79M $59.15M $85.11M $195.6M $284.1M
Other Non-Current Assets $3.62M $2.33M $6.60M $9.58M $9.38M $9.39M $9.56M $9.38M $8.94M $9.04M
Total Non-Current Assets $158.2M $245.3M $183.7M $240.0M $270.9M $268.7M $292.8M $325.4M $442.6M $508.3M
Total Assets $415.9M $548.7M $642.8M $713.4M $773.0M $750.1M $821.6M $894.5M $955.6M $978.1M
Accounts Payable $4.27M $5.39M $5.90M $6.21M $10.23M $14.69M $13.89M $11.04M $9.71M $8.71M
Deferred Revenue (Current) -- -- $86K $86K $86K $86K $95K $99K $104K $147K
Other Current Liabilities $2.40M $1.07M $1.81M -- -- -- $2.12M -- -- --
Total Current Liabilities $32.51M $35.52M $37.08M $37.49M $54.58M $59.40M $53.73M $48.08M $44.18M $36.62M
Other Non-Current Liabilities $15.80M $7.76M $5.18M $5.19M $5.20M $5.21M $5.85M $6.29M $6.73M $7.17M
Total Non-Current Liabilities $90.85M $91.01M $93.53M $95.29M $97.02M $98.72M $101.0M $103.0M $105.0M $76.20M
Total Liabilities $123.4M $126.5M $130.6M $132.8M $151.6M $158.1M $154.7M $151.1M $149.1M $112.8M
Total Debt (incl. Leases) $83.25M $90.76M $95.12M $96.68M $98.20M $99.70M $101.1M $102.5M $103.6M $72.62M
Common Stock $229K $212K $169K $168K $167K $146K $144K $144K $144K $143K
Retained Earnings -$2.01B -$1.82B -$1.56B -$1.48B -$1.41B -$1.33B -$1.23B -$1.14B -$1.05B -$973.2M
Accumulated Other Comp. Income $269K -$89K -$955K -$2.41M -$3.85M -$5.93M -$9.93M -$12.96M -$11.47M -$9.25M
Total Stockholders' Equity $292.5M $422.2M $512.2M $580.6M $621.4M $592.0M $666.9M $743.4M $806.5M $865.3M
Total Equity $292.5M $422.2M $512.2M $580.6M $621.4M $592.0M $666.9M $743.4M $806.5M $865.3M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $29.27M $38.63M $30.31M $51.69M $37.81M $52.33M $42.45M $75.22M
Short-Term Investments $263.7M $294.0M $236.6M $198.5M $214.4M $220.8M $237.6M $217.3M
Cash & Short-Term Investments $388.9M $423.6M $266.9M $258.3M $277.1M $302.6M $335.5M $373.1M
Total Current Assets $299.8M $340.0M $273.3M $257.7M $260.7M $282.7M $291.6M $303.4M
Property, Plant & Equipment, Net $64.82M $67.38M $70.02M $72.84M $75.90M $78.86M $82.99M $86.06M
Long-Term Investments $95.92M $90.99M $0 $8.04M $24.94M $29.51M $55.51M $80.67M
Other Non-Current Assets $3.82M $3.69M $3.53M $3.62M $3.51M $3.83M $1.90M $2.33M
Total Non-Current Assets $211.5M $210.1M $122.7M $158.2M $179.1M $187.9M $216.4M $245.3M
Total Assets $511.3M $550.1M $396.0M $415.9M $439.8M $470.6M $508.0M $548.7M
Accounts Payable $8.78M $5.96M $4.93M $4.27M $3.70M $4.85M $5.06M $5.39M
Other Current Liabilities -- -- -- $2.40M -- -- -- $1.07M
Total Current Liabilities $38.50M $31.73M $28.33M $32.51M $31.83M $31.68M $30.02M $35.52M
Other Non-Current Liabilities $12.23M $11.84M $16.12M $15.80M $15.47M $15.12M $11.28M $7.76M
Total Non-Current Liabilities $80.27M $82.19M $88.75M $90.85M $92.61M $94.36M $92.57M $91.01M
Total Liabilities $118.8M $113.9M $117.1M $123.4M $124.4M $126.0M $122.6M $126.5M
Total Debt (incl. Leases) $76.94M $79.01M $81.05M $83.25M $85.14M $87.00M $88.92M $90.76M
Common Stock $346K $345K $245K $229K $223K $220K $219K $212K
Retained Earnings -$2.15B -$2.10B -$2.05B -$2.01B -$1.97B -$1.93B -$1.88B -$1.82B
Accumulated Other Comp. Income -$1.44M -$518K -$183K $269K $235K -$45K $43K -$89K
Total Stockholders' Equity $392.6M $436.2M $278.9M $292.5M $315.3M $344.6M $385.4M $422.2M
Total Equity $392.6M $436.2M $278.9M $292.5M $315.3M $344.6M $385.4M $422.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$190.9M -$257.6M -$327.3M -$340.4M -$182.1M -$250.2M -$184.6M -$211.5M
Depreciation & Amortization $12.36M $13.64M $14.20M $14.30M $10.50M $7.40M $4.60M $1.00M
Stock-Based Compensation $37.64M $51.74M $65.95M $83.60M $80.82M $65.26M $46.06M $18.57M
Change in Payables -$1.23M -$503K -$7.50M $4.87M -$767K $615K -$985K $8.80M
Operating Cash Flow -$149.2M -$200.3M -$237.7M -$220.5M -$184.8M -$115.1M -$137.3M -$44.65M
Capital Expenditure -$386K -$694K -$1.52M -$5.19M -$21.45M -$65.96M -$50.79M -$3.23M
Free Cash Flow -$149.6M -$201.0M -$239.2M -$225.7M -$206.3M -$181.1M -$188.1M -$47.89M
Purchases of Investments -$138.3M -$361.5M -$438.6M -$248.1M -$525.6M -$1.04B -$252.6M -$649.3M
Sales & Maturities of Investments $234.2M $437.9M $603.4M $359.5M $728.4M -- -- --
Investing Cash Flow $95.56M $75.69M $163.3M $106.2M $163.7M -$505.1M $164.1M -$632.8M
Common Stock Issued -- -- $91.11M $0 $0 $595.7M $0 $343.7M
Financing Cash Flow $30.16M $116.7M $95.69M $2.95M $11.96M $633.6M $58.96M $771.2M
Net Change in Cash -$23.53M -$7.94M $21.25M -$111.4M -$9.19M $13.38M $85.69M $93.73M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$50.37M -$42.68M -$42.61M -$38.81M -$41.40M -$50.94M -$59.73M -$59.94M
Depreciation & Amortization $2.59M $2.65M $2.87M $3.06M $3.10M $3.11M $3.10M $3.23M
Stock-Based Compensation $7.03M $12.44M $8.27M $8.13M $8.65M $8.69M $12.18M $12.87M
Change in Payables $2.81M $1.03M $663K $599K -$1.07M -$422K -$336K $34K
Operating Cash Flow -$36.12M -$32.00M -$12.91M -$27.60M -$29.69M -$39.03M -$52.93M -$36.70M
Capital Expenditure -$25K -$150K -$9.0K $0 -$243K -$44K -$99K -$257K
Free Cash Flow -$36.14M -$32.15M -$12.92M -$27.60M -$29.93M -$39.07M -$53.03M -$36.95M
Purchases of Investments -$46.06M -$183.7M -$101.7M -$28.38M -$49.73M -$9.92M -$50.23M -$46.97M
Sales & Maturities of Investments -- -- -- -- -- -- -- $102.2M
Investing Cash Flow $26.12M -$147.6M -$29.59M $33.61M $11.94M $43.84M $6.18M $54.93M
Common Stock Issued -- -- -- -- -- -- $10.00M --
Financing Cash Flow $646K $187.9M $21.12M $7.86M $3.24M $5.07M $13.99M $5.74M
Net Change in Cash -$9.36M $8.32M -$21.38M $13.87M -$14.52M $9.88M -$32.76M $23.98M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -1241813.6% -344986.3% -215087.2% -157.9% -- -- --
Net Profit Margin -- -1170863.6% -344489.5% -218214.1% -159.6% -- -- --
Return on Equity (ROE) -65.3% -61.0% -63.9% -51.0% -19.7% -24.7% -29.3% -30.1%
Return on Assets (ROA) -45.9% -46.9% -50.9% -41.4% -17.5% -20.4% -25.7% -27.3%
Current Ratio 7.93x 8.54x 12.38x 9.84x 9.78x 8.96x 16.46x 15.89x
Quick Ratio 7.94x 10.50x 12.10x 10.73x 16.80x 10.60x 17.80x 24.49x
Debt to Equity 0.28x 0.21x 0.19x 0.15x 0.08x 0.05x 0.08x 0.05x
Revenue Growth (YoY) -100.0% -76.8% -39.1% -99.9% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -- -- -- -1241813.6%
Net Profit Margin -- -- -- -- -- -- -- -1170863.6%
Return on Equity (ROE) -44.4% -37.9% -62.3% -65.3% -67.2% -68.8% -65.5% -61.0%
Return on Assets (ROA) -34.1% -30.1% -43.9% -45.9% -48.2% -50.3% -49.7% -46.9%
Current Ratio 7.79x 10.72x 9.65x 7.93x 8.19x 8.92x 9.71x 8.54x
Quick Ratio 10.10x 13.35x 9.42x 7.94x 8.70x 9.55x 11.18x 10.50x
Debt to Equity 0.20x 0.18x 0.29x 0.28x 0.27x 0.25x 0.23x 0.21x
Revenue Growth (YoY) -- -- -- -- -- -- -100.0% -100.0%
Source: SEC EDGAR CompanyFacts (CIK 0001737287) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:39 UTC · Open in terminal